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respiratory motion whilst using the device, but that 
interpretation of the visualization schemes can be quite 
literal. This can lead, for example, to ‘target driven’ 
pulsatile breath holding rather than quiescent, smooth 
motion patterns.  
Conclusions: This interim analysis shows that the visual 
feedback device is well tolerated in lung cancer patients. The 
optical surface measurement technology delivers fast and 
accurate skin surface measurements. However, great care 
must be taken with the psychology of visual feedback schema 
in order to encourage predictable patient response. 
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Purpose/Objective: Rectal toxicity is one the major 
constraints in prostate cancer radiotherapy (RT). It has been 
shown that various manifestations of rectal toxicity strongly 
correlate with the dose distribution on the surface of the 
rectum (Buettner at al., Phys. Med. Biol. 2009). IGRT daily 
images can be used to re-compute rectum doses for each 
treatment fraction whilst accounting for intra-fraction 
variations in rectum position. As a part of the VoxTox study 
we are analyzing re-computed doses and toxicity in over 1000 
patients treated with image-guided intensity-modulated 
radiotherapy (IG-IMRT) using TomoTherapy. The length of the 
IG scan is kept short for clinical care. We examined whether 
it was sufficient for this research. 
Materials and Methods: We include both retrospective and 
prospective cohorts of prostate cancer patients and acquire 
acute and late toxicity data with a follow-up of 5 years. The 
retrospective cohort was imaged using the standard (STD) 
protocol that is designed to minimize the imaged area whilst 
still enabling soft tissue matching to the prostate. For the 
prospective cohort, we have created a dedicated imaging 
protocol to extend the scan to cover the entire PTV inclusive 
of nodal regions and seminal vesicles. We have demonstrated 
that increases in imaging dose and scan times are negligibly 
small (Bates et. al., Br J Radiol. 2013). This work compares 
the differences in imaging data acquired using STD and 
VoxTox imaging protocols. One oncologist outlined the 
rectum on the planning CT and 37 daily megavoltage CT 
images of patients treated to 74 Gy in 37 fractions. The 
rectum contours on daily images were adjusted to include 
positional corrections applied by treatment radiographers 
prior to RT delivery. A median dose to the rectal surface was 
calculated for all slices in the planning and daily CT images.  
Results: The results from retrospective and from prospective 
cohorts are presented in Figure 1. 
 
 
 
Images acquired using the STD protocol truncate the rectum 
that lies superior of the prostate. In the majority of STD MV 
scans, large parts of rectum receiving doses of 60 Gy and 
above are omitted. For patients imaged according to the 
VoxTox protocol, sufficient coverage of the rectum is 
achieved to account for daily variations in prostate position 
and to enclose all areas of rectum that receive median doses 
of 50 Gy or higher. 
Conclusions: A imaging protocol tailored for research is 
essential to design a prospective study that focuses on rectal 
toxicity. The imaged area in daily scans can be expanded 
with negligible increase in imaging dose and scan time, and 
helps to compensate for daily organ motion. The enhanced 
scans contain all clinically significant data and are useful in 
understanding of dose-toxicity links. Median dose per slice 
evaluation will be useful as a quality assessment tool for 
stratification and analysis of re-calculated daily doses. 
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